Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2005;32(3):339-47.

Stem celltherapy for ischemic heart failure

Doreen Rosenstrauch  1 , Gregor Poglajen, Nina Zidar, Igor D Gregoric
Affiliations
Review

Stem celltherapy for ischemic heart failure

Doreen Rosenstrauch et al. Tex Heart Inst J. 2005.

Abstract

As the prevalence and incidence of ischemic heart disease continue to increase, so does interest in ischemic heart failure management. Limitations of current therapies have led to research aimed at regenerating and repairing ischemically damaged myocardium through stem-cell therapy. Cell types being evaluated include embryonic stem cells, fetal and neonatal cardiomyocytes, skeletal myoblasts, bone marrow stem cells, peripheral blood CD34+ cells, endothelial progenitor cells, cardiac progenitor cells, and fibroblasts. Preclinical animal studies and promising early results of clinical trials now under way suggest that stem-cell therapy may soon become an important new tool in heart failure management.

PubMed Disclaimer

References

    1. Menasche P. Cell transplantation in myocardium. Ann Thorac Surg 2003;75(6 Suppl):S20–8. - PubMed
    1. Anversa P, Kajstura J. Ventricular myocytes are not terminally differentiated in the adult mammalian heart. Circ Res 1998;83:1–14. - PubMed
    1. Beltrami AP, Urbanek K, Kajstura J, Yan SM, Finato N, Bussani R, et al. Evidence that human cardiac myocytes divide after myocardial infarction. N Engl J Med 2001;344: 1750–7. - PubMed
    1. Mangi AA, Noiseux N, Kong D, He H, Rezvani M, Ingwall JS, Dzau VJ. Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts. Nat Med 2003;9:1195–201. - PubMed
    1. Hughes S. Cardiac stem cells. J Pathol 2002;197:468–78. - PubMed

Publication types